Active — Not RecruitingPhase 2

Oral Iron Supplementation for Patients With Chronic Kidney Disease

Brazil6 participantsStarted 2022-08-01

Plain-language summary

The hypothesis of this research is that oral iron prescribed in a single dose in alternate day could mitigate the side effects with regard to intestinal microbiota, inflammation, oxidative stress and improve the hematological profile when compared to daily oral iron prescription

Who can participate

Age range18 Years – 75 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: Aged 18 to 75 years Clinical diagnosis of Chronic Kidney Disease Conservative treatment group: chronic kidney disease stages 3 and 5 Exclusion Criteria: * Patients pregnant * Smokers * Using antibiotics in the last 3 months * Autoimmune diseases * Clinical diagnosis of infectious diseases * Clinical diagnosis of Cancer * Clinical diagnosis of AIDS

What they're measuring

Change in cytokines plasma levels measured by ELISA after supplementation with oral iron

Timeframe: 2 months

Trial details

NCT IDNCT05544513

SponsorUniversidade Federal Fluminense

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2026-12-29

View on ClinicalTrials.gov More Chronic Renal Disease trials